A note for UK readers

This page explains Kenya’s system. Its licences, funding rules and prescribing criteria do not determine access in the UK.

What should I verify besides the medicine's brand name?

Check the specific product's current PPB status, the authorised use and the dispensing premises' licence.

Read current product information

PPB hosts Wegovy product information describing weight management in defined groups. It also hosts separate Ozempic information for type 2 diabetes. These documents should not be merged into a single claim that every semaglutide product has the same indication.

Keep availability separate

A published product document does not tell you whether a nearby pharmacy can supply the prescribed pack today. Have the clinician and pharmacist verify current registration, the appropriate product and continuity of supply before making a payment.

Verify the pharmacy licence

PPB explains that outlet registration is continuously updated and that authorised premises have licences with QR codes for verification. Use its current register or licence check rather than a saved list or a seller's own assurance.

Where this guide stops

This review did not verify a nationwide funded obesity-treatment entitlement or a reliable Kenyan retail price. UK readers should not infer UK access from PPB documents or convert a KES advertisement into a saving. Use the UK guide for a local care decision.

Keep these four questions separate

Access

Kenyan product and pharmacy verification through PPB

Funding

National obesity-treatment entitlement not verified

Cost context

No national KES price or UK saving asserted

Regulatory source

Pharmacy and Poisons Board

Compare health systems ↗
Follow the evidence

Sources & further reading

Sources checked . These links support the information above; they do not imply endorsement of this website.

  1. PPB: Wegovy product information
  2. PPB: Ozempic product information
  3. PPB: how to verify licensed pharmaceutical outlets
A note on this guide

Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.

Read our editorial standards →